431. Lung antibody factory for passive immunisation against influenza

431. Lung antibody factory for passive immunisation against influenza

Bibliographic Details
Main Authors:	Tan, T, Rijal, P, Davies, L, Pringle, I, Townsend, A, Hyde, S, Gill, D
Format:	Conference item
Published:	Cell Press 2016

Similar Items

Lung-targeted lentiviral vector mediates passive immunisation against influenza
by: Tan, T, et al.
Published: (2018)

Lung-targeting lentiviral vector for passive immunisation against influenza
by: Tan, TK, et al.
Published: (2020)

Development of recombinant Adeno-Associated Viral vector (rAAV) for passive immunisation against ebola
by: Tan, T, et al.
Published: (2017)

Lentiviral-mediated expression of monoclonal antibodies in the lung to protect against influenza
by: Du, Y, et al.
Published: (2020)

Development of viral vectors for passive immunisation against influenza
by: Tan, TK
Published: (2017)

Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies
by: Antepowicz, A, et al.
Published: (2016)

Immunisation against influenza during pregnancy.
by: Knight, M, et al.
Published: (2012)

Respiratory immunisation and mucosal immunity against influenza
by: Martini, V
Published: (2022)

Cardiac transplantation and immunisation against Haemophilus influenzae.
by: Barbour, M, et al.
Published: (1993)

Immunisation against influenza during pregnancy The benefits outweigh the risks
by: Knight, M, et al.
Published: (2012)

The development of gene therapy for diseases of the lung.
by: Gill, DR, et al.
Published: (2004)

Use of pseudotyped, replication deficient influenza to facilitate testing of gene delivery strategies for treatment of highly infectious diseases
by: Tan, T, et al.
Published: (2018)

The lung as a factory to produce secreted intrapulmonary and circulatory proteins
by: Paul-Smith, M, et al.
Published: (2017)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
by: Pringle, I, et al.
Published: (2018)

Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T.
by: Heath, P, et al.
Published: (1997)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
by: Pringle, I, et al.
Published: (2018)

The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins
by: Paul-Smith, M, et al.
Published: (2018)

Development of lung and muscle factories to deliver therapeutic monoclonal antibodies
by: Antepowicz, A
Published: (2018)

A study of human monoclonal antibodies to influenza and ebola viruses
by: Rijal, P
Published: (2016)

Challenges in immunisation against bacterial infection in children.
by: Trück, J, et al.
Published: (2010)

Maternal antibody interference, immunisation schedules, and protective antibody levels in infants
by: Voysey, M
Published: (2018)

A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
by: Munday, R, et al.
Published: (2018)

Lung directed antibody gene transfer confers protection against SARS-CoV-2 infection
by: Yue, D, et al.
Published: (2022)

Influence of CpG-dinucleotide motifs on the duration of gene expression from plasmid, vectors after in vivo lung delivery
by: Gill, DR, et al.
Published: (2007)

Topical delivery of NF-kb decoy related oligodeoxynucleotides reduces pro-inflammatory cytokine response associated with cationic lipid: pDNA vector delivery to murine lungs
by: Varathalingam, et al.
Published: (2004)

A qualitative study of lay beliefs about influenza immunisation in older people.
by: Evans, MR, et al.
Published: (2007)

743. Minicircles are similar to plasmids in providing high level, long-term expression in the lung
by: Gill, D, et al.
Published: (2016)

DNA immunization for production in egg factory of protective antibodies against hepadnavirus infection
by: Rollier, C, et al.
Published: (1999)

The price of prevention: what now for immunisation against meningococcus B?
by: Moxon, R, et al.
Published: (2013)

Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection.
by: Fox, A, et al.
Published: (2015)

Immunisation status in hospitalised infants: reasons for incomplete immunisation
by: Othman, Norlijah, et al.
Published: (2005)

Genetic immunisation
by: Johnson, T, et al.
Published: (2021)

DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY
by: Gill, DR, et al.
Published: (2010)

Viral vectors for immunisation against potassium channel Kv1.2
by: McKnight, K, et al.
Published: (2005)

Autocratic legacies and immunisation against extremism: a rational choice approach
by: Leão, C
Published: (2022)

Transgene sequences free of CG dinucleotides lead to high level, long-term expression in the lung independent of plasmid backbone design
by: Bazzani, R, et al.
Published: (2016)

Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1
by: McLean, Gary R., et al.
Published: (2012)

LUNG-CANCER AND PASSIVE SMOKING - RESPONSE
by: Darby, S, et al.
Published: (1990)

Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques
by: Alter, Galit, et al.
Published: (2021)

Immunisation of the immunocompromised child
by: Pinto, M, et al.
Published: (2016)